A SAFE

Details for Australian Patent Application No. 2002337409 (hide)

Owner GILGAMESH LIMITED

Inventors ANDERSON, Malcolm, Donald; BEAUMONT, Nicholas, George

Pub. Number AU-A-2002337409

PCT Number PCT/IB02/03991

PCT Pub. Number WO2003/034348

Priority 2001/8567 18.10.01 ZA; 2002/7029 02.09.02 ZA

Filing date 27 September 2002

Wipo publication date 28 April 2003

International Classifications

G07C 009/00 Individual entry or exit registers

Event Publications

20 February 2003 Complete Application Filed

  Priority application(s): 2001/8567 18.10.01 ZA; 2002/7029 02.09.02 ZA

3 July 2003 Application Open to Public Inspection

  Published as AU-A-2002337409

8 July 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002337410-TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA, RESISTANT OR INTOLERANT TO STI571, INVOLVING HOMOHARRINGTONINE ALONE OR COMBINED WITH OTHER AGENTS

2002337408-Piperazine derivatives with CCR1 receptor antagonist activity